medpundit |
||
|
Friday, September 09, 2005Concerns were expressed during the panel's meeting about use of Exubera by people with lung disease or those exposed to second-hand cigarette smoke. Tests of the drug have shown that chronic smokers tend to absorb more insulin than non-smokers. That could result in a higher risk of hypoglycemia, which can cause dizziness and blackouts. Pfizer executives at the Thursday meeting said the product's label would warn smokers against using the product. Studies also showed people taking the inhaled insulin had more cases of severe asthma. Pfizer executives said Thursday that they would monitor people taking the drug after it is approved for sale. Paul Woolf, the committee chairman, who is head of the department of medicine at Crozer Chester Medical Center in Upland, Pa., voted not to recommend Exubera. So did James Stoller, head of respiratory therapy at the Cleveland Clinic's pulmonary and critical care medicine division. posted by Sydney on 9/09/2005 08:08:00 AM 0 comments 0 Comments: |
|